Health Capital Helsinki
  • Home
  • Why Helsinki Metropolitan
  • About us
  • News
  • Events
  • Opportunities
  • Careers
  • Contact
  • Search
  • Menu Menu
© Unsplash
Jun 17, 2021

Presenting Health Incubator Helsinki batch 2 companies:

Finnadvance develops microfluidic organ-on-chips for pharmaceutical drug R&D

Finnadvance manufactures multi-channel 3-D microfluidic organ-on-a-chips that simulate the activities, mechanics and physiological response of entire organs and organ systems. The company is one of the promising health startups selected for the Health Incubator Helsinki program that started in the spring of 2021.

What the above means, in essence, is that the Finnish, Oulu-based startup simulates the human body’s physiology on a microfluidic device, where small tissue and organ fragments are grown for molecule and drug testing.

“The technology allows more human-like pre-clinical drug testing, fast repurposing of old drugs and, in the long term, development of personalized therapies and medicines,” explains Finnadvance’s CEO Prateek Singh.

Catch the future

Finnadvance has a vision where organ-on-chips will significantly speed the development of new drugs, as well as abolish the need for animals in drug development and toxin testing. The goal at Finnadvance is to create a body-on-a-chip which could be used to test medications and treatments before they are administered to a patient, says Singh.

“This way, performance of different medications and treatments could be tested in advance and the patient would receive only the best, most suitable medication. Selecting the right medication with organ- or body-on-chips both speeds up the process substantially and greatly improves the safety as well as patient outcomes,” says Singh, admitting that the concept may sound “futuristic”, but it’s closer than you might think.

“This can all be a reality in 10 years,” he believes.

Prateek Singh, Finnadvance
Jonas Simberg

Prateek Singh, CEO of Finnadvance

Selecting the right medication with organ- or body-on-chips speeds up the process substantially and greatly improves safety and patient outcomes.

Best networks

Founded in December 2018, Finnadvance has already established joint research and collaboration with partners and customers such as the Finnish Red Cross Blood Service, Orion Pharma, University of Helsinki, University of Eastern Finland, Tampere University, VTT Oulu, UPM Biomedicals, the Biobank of Eastern Finland and SMEs Kaivogen, Timegate Instruments, Bionavis, and Afekta.

This year, Prateek Singh was one of the four finalists for the Young Researcher Entrepreneur Award by Kaute Foundation. The award is granted annually to an entrepreneur who has created a new research-based business. Despite being recognised for his entrepreneurial prowess now more and more, Singh says that his “real identity” is different.

“I see myself as a researcher and a scientist, but sometimes you must have your own business to push things along and achieve real progress,” he says.

Finnadvance team in lab coats and face masks
Finnadvance

Finnadvance team

© Unsplash

“In a lot of areas, Finnish research is far ahead of the field.”

When duty calls

Originally, Singh founded Finnadvance with a vision to make drug discovery more transparent and predictable. The idea for Finnadvance came together during Singh’s 15 years of studies in biotechnology, biochemistry and protein science.

“This was something that I wanted to pursue, but I didn’t really know whether it would be in the form of a company or a research project,” he looks back.

Then, having seen some gaps in the research field, he decided to put together a startup.

“I feel that it’s a duty, in a sense, to promote these innovations.”

Singh started building a team for developing platform technologies for in-vitro development of drugs and therapies. Since then, Finnadvance team has grown to 15 people and is now scaling the platform to accelerate drug development processes.

“By 2025, we aim to have 65 people working here.”

Get the word out!

Born in India, Singh has more than a decade of experience from the Finnish health ecosystem, having come to Finland as part of a work exchange program already in 2009. He says that the ecosystem holds a wide range of expertise that the world might not necessarily know about – yet.

“In a lot of areas, Finnish research is far ahead of the field,” he says, adding that there’s no reason to stop now:

“The Finnish health ecosystem can do even better in the future.”

Participating in the second program of Health Incubator Helsinki, that started in April 2021, Finnadvance is eager to learn as much as possible and network to the max.

“We have high expectations for the program. For example, the program mentors are really excellent,” says Singh.

In addition, Finnadvance was recently selected for the EIT Health Catapult Semi-finals – as one of 42 health startups from Europe and the only one in biotech category from Finland. The semifinalists are in for intensive training from experts, meeting investors and corporates, and finally in December 2021, competing in pitch contests to progress to finals.

Check out all the companies in the Health Incubator Helsinki program

Text: Sami J. Anteroinen

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn

Finnadvance logo and name

Fast Facts

Name: Finnadvance

Product: Manufactures multi-channel 3-D microfluidic organ-on-a-chips

Founded: 2018

Team size: 15

Target customer/market: Medical professionals & researchers

More case stories

Health Capital Helsinki

Pohjoisranta and Halkolaituri from aboveJussi Hellsten / City of Helsinki

Lapsi Health harnesses sound to boost health

Jun 1, 2022
Read more
https://healthcapitalhelsinki.fi/wp-content/uploads/2022/06/Pohjoisranta_H365_2019_0417_Jussi_Hellsten.jpg 1000 1500 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2022-06-01 08:00:072022-06-02 15:08:59Lapsi Health harnesses sound to boost health
Woman in a pink shirt testing VR glassesN2 Albiino / Helsinki Partners

Virtual reality to improve nursing education in Finland

Feb 16, 2022
Read more
https://healthcapitalhelsinki.fi/wp-content/uploads/2022/02/Woman-in-pink-wearing-VR-glasses2-w1200.jpg 1125 1500 taruvirtanen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png taruvirtanen2022-02-16 13:44:182022-02-16 15:28:11Virtual reality to improve nursing education in Finland
Two people with sunglasses leaning against a building wallJussi Hellsten / Helsinki Marketing

Trialwell connects people and researchers for a clinical trial win-win

Nov 10, 2021
Read more
https://healthcapitalhelsinki.fi/wp-content/uploads/2021/10/20140317_1658_L1001371-Edit_4062.jpg 1180 2000 Saana Lehtinen https://healthcapitalhelsinki.fi/wp-content/uploads/2020/02/hch_logo_horizontal_black-300x165-1.png Saana Lehtinen2021-11-10 07:25:032021-11-08 11:13:59Trialwell connects people and researchers for a clinical trial win-win
News

Health Capital Helsinki

Helsinki Partners
Kasarmikatu 36
00130 HELSINKI
FINLAND

Privacy notice

Sign up to our newsletter

Subscribe

Follow us

  • twitter
  • linkedin
Health Capital Helsinki

We use cookies to give you the best experience on our website.

Find out more and set your preferences settings.

Powered by  GDPR Cookie Compliance
How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential website cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are necessary to deliver the website as intended, refusing them will have impact how our site functions. You can always block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will prompt you to accept or refuse cookies every time you revisit our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Third party cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages. Keeping this cookie enabled helps us to improve our website.

We also use Twitter's and LinkedIn's cookies to help us improve our content and reach.

Please enable essential website cookies first so that we can save your preferences!

Privacy notice

You can read about how we use your data on our Privacy notice page.

Privacy notice

Scroll to top